2018-2023 Global Blood Plasma Derivatives Consumption Market Report

October 2018 | 161 pages | ID: 2025080D773EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Blood Plasma Derivatives market for 2018-2023.

Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and blood disorders in the body. Plasma derivatives are the concentrates of specific proteins, which require pooling of plasma from large number of donors. For instance, they require more than hundred plasma donations to produce sufficient immunoglobulin to treat an immune-deficient patient for one year. They are obtained by the process of fractionation where protein concentrates are separated and then clinically used.
The growth of the global blood plasma derivatives market is majorly driven by increase in prevalence of life-threatening disorders, especially hemophilia. Other factors boosting the market growth include rise in adoption of blood plasma derivatives products, upsurge in geriatric population across the world, and increase in awareness about blood & plasma donation. However, factors such as high cost of plasma derivative-based therapy and post-operative risks associated with plasma replacement therapy hamper the market growth. Conversely, the development of enhanced methods for preservation of plasma derivatives along with advanced procedures for fractionation and high potential in untapped markets in the emerging economies are expected to provide lucrative growth opportunities for the market.
Over the next five years, LPI(LP Information) projects that Blood Plasma Derivatives will register a 9.7% CAGR in terms of revenue, reach US$ 43300 million by 2023, from US$ 24800 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Blood Plasma Derivatives market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Albumin
• Factor VIII
• Factor IX
• Immunoglobulin
• Hyperimmune Globulin
• Others

Segmentation by application:

• Hospitals
• Clinics
• Other End Users

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Grifols, S.A.
• SK Plasma Co., Ltd.
• Fusion Health Care Pvt. Ltd.
• Biotest AG
• Green Cross Corporation
• Baxter International Inc.
• LFB S.A.
• Octapharma AG
• CSL Limited
• Shire Plc.
• China Biologic Products, Inc.
• Kedrion Biopharma, Inc.
• BDI Pharma, Inc.
• Bayer AG
• Hualan Biological Engineering, Inc.

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Blood Plasma Derivatives consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Blood Plasma Derivatives market by identifying its various subsegments.
• Focuses on the key global Blood Plasma Derivatives manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Blood Plasma Derivatives with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Blood Plasma Derivatives submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Blood Plasma Derivatives Consumption 2013-2023
  2.1.2 Blood Plasma Derivatives Consumption CAGR by Region
2.2 Blood Plasma Derivatives Segment by Type
  2.2.1 Albumin
  2.2.2 Factor VIII
  2.2.3 Factor IX
  2.2.4 Immunoglobulin
  2.2.5 Hyperimmune Globulin
  2.2.6 Others
2.3 Blood Plasma Derivatives Consumption by Type
  2.3.1 Global Blood Plasma Derivatives Consumption Market Share by Type (2013-2018)
  2.3.2 Global Blood Plasma Derivatives Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Blood Plasma Derivatives Sale Price by Type (2013-2018)
2.4 Blood Plasma Derivatives Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Other End Users
2.5 Blood Plasma Derivatives Consumption by Application
  2.5.1 Global Blood Plasma Derivatives Consumption Market Share by Application (2013-2018)
  2.5.2 Global Blood Plasma Derivatives Value and Market Share by Application (2013-2018)
  2.5.3 Global Blood Plasma Derivatives Sale Price by Application (2013-2018)

3 GLOBAL BLOOD PLASMA DERIVATIVES BY PLAYERS

3.1 Global Blood Plasma Derivatives Sales Market Share by Players
  3.1.1 Global Blood Plasma Derivatives Sales by Players (2016-2018)
  3.1.2 Global Blood Plasma Derivatives Sales Market Share by Players (2016-2018)
3.2 Global Blood Plasma Derivatives Revenue Market Share by Players
  3.2.1 Global Blood Plasma Derivatives Revenue by Players (2016-2018)
  3.2.2 Global Blood Plasma Derivatives Revenue Market Share by Players (2016-2018)
3.3 Global Blood Plasma Derivatives Sale Price by Players
3.4 Global Blood Plasma Derivatives Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Blood Plasma Derivatives Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Blood Plasma Derivatives Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 BLOOD PLASMA DERIVATIVES BY REGIONS

4.1 Blood Plasma Derivatives by Regions
  4.1.1 Global Blood Plasma Derivatives Consumption by Regions
  4.1.2 Global Blood Plasma Derivatives Value by Regions
4.2 Americas Blood Plasma Derivatives Consumption Growth
4.3 APAC Blood Plasma Derivatives Consumption Growth
4.4 Europe Blood Plasma Derivatives Consumption Growth
4.5 Middle East & Africa Blood Plasma Derivatives Consumption Growth

5 AMERICAS

5.1 Americas Blood Plasma Derivatives Consumption by Countries
  5.1.1 Americas Blood Plasma Derivatives Consumption by Countries (2013-2018)
  5.1.2 Americas Blood Plasma Derivatives Value by Countries (2013-2018)
5.2 Americas Blood Plasma Derivatives Consumption by Type
5.3 Americas Blood Plasma Derivatives Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Blood Plasma Derivatives Consumption by Countries
  6.1.1 APAC Blood Plasma Derivatives Consumption by Countries (2013-2018)
  6.1.2 APAC Blood Plasma Derivatives Value by Countries (2013-2018)
6.2 APAC Blood Plasma Derivatives Consumption by Type
6.3 APAC Blood Plasma Derivatives Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Blood Plasma Derivatives by Countries
  7.1.1 Europe Blood Plasma Derivatives Consumption by Countries (2013-2018)
  7.1.2 Europe Blood Plasma Derivatives Value by Countries (2013-2018)
7.2 Europe Blood Plasma Derivatives Consumption by Type
7.3 Europe Blood Plasma Derivatives Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Blood Plasma Derivatives by Countries
  8.1.1 Middle East & Africa Blood Plasma Derivatives Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Blood Plasma Derivatives Value by Countries (2013-2018)
8.2 Middle East & Africa Blood Plasma Derivatives Consumption by Type
8.3 Middle East & Africa Blood Plasma Derivatives Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Blood Plasma Derivatives Distributors
10.3 Blood Plasma Derivatives Customer

11 GLOBAL BLOOD PLASMA DERIVATIVES MARKET FORECAST

11.1 Global Blood Plasma Derivatives Consumption Forecast (2018-2023)
11.2 Global Blood Plasma Derivatives Forecast by Regions
  11.2.1 Global Blood Plasma Derivatives Forecast by Regions (2018-2023)
  11.2.2 Global Blood Plasma Derivatives Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Blood Plasma Derivatives Forecast by Type
11.8 Global Blood Plasma Derivatives Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Grifols, S.A.
  12.1.1 Company Details
  12.1.2 Blood Plasma Derivatives Product Offered
  12.1.3 Grifols, S.A. Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Grifols, S.A. News
12.2 SK Plasma Co., Ltd.
  12.2.1 Company Details
  12.2.2 Blood Plasma Derivatives Product Offered
  12.2.3 SK Plasma Co., Ltd. Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 SK Plasma Co., Ltd. News
12.3 Fusion Health Care Pvt. Ltd.
  12.3.1 Company Details
  12.3.2 Blood Plasma Derivatives Product Offered
  12.3.3 Fusion Health Care Pvt. Ltd. Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Fusion Health Care Pvt. Ltd. News
12.4 Biotest AG
  12.4.1 Company Details
  12.4.2 Blood Plasma Derivatives Product Offered
  12.4.3 Biotest AG Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Biotest AG News
12.5 Green Cross Corporation
  12.5.1 Company Details
  12.5.2 Blood Plasma Derivatives Product Offered
  12.5.3 Green Cross Corporation Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Green Cross Corporation News
12.6 Baxter International Inc.
  12.6.1 Company Details
  12.6.2 Blood Plasma Derivatives Product Offered
  12.6.3 Baxter International Inc. Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Baxter International Inc. News
12.7 LFB S.A.
  12.7.1 Company Details
  12.7.2 Blood Plasma Derivatives Product Offered
  12.7.3 LFB S.A. Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 LFB S.A. News
12.8 Octapharma AG
  12.8.1 Company Details
  12.8.2 Blood Plasma Derivatives Product Offered
  12.8.3 Octapharma AG Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Octapharma AG News
12.9 CSL Limited
  12.9.1 Company Details
  12.9.2 Blood Plasma Derivatives Product Offered
  12.9.3 CSL Limited Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 CSL Limited News
12.10 Shire Plc.
  12.10.1 Company Details
  12.10.2 Blood Plasma Derivatives Product Offered
  12.10.3 Shire Plc. Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Shire Plc. News
12.11 China Biologic Products, Inc.
12.12 Kedrion Biopharma, Inc.
12.13 BDI Pharma, Inc.
12.14 Bayer AG
12.15 Hualan Biological Engineering, Inc.

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Blood Plasma Derivatives
Table Product Specifications of Blood Plasma Derivatives
Figure Blood Plasma Derivatives Report Years Considered
Figure Market Research Methodology
Figure Global Blood Plasma Derivatives Consumption Growth Rate 2013-2023 (K Units)
Figure Global Blood Plasma Derivatives Value Growth Rate 2013-2023 ($ Millions)
Table Blood Plasma Derivatives Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Albumin
Table Major Players of Albumin
Figure Product Picture of Factor VIII
Table Major Players of Factor VIII
Figure Product Picture of Factor IX
Table Major Players of Factor IX
Figure Product Picture of Immunoglobulin
Table Major Players of Immunoglobulin
Figure Product Picture of Hyperimmune Globulin
Table Major Players of Hyperimmune Globulin
Figure Product Picture of Others
Table Major Players of Others
Table Global Consumption Sales by Type (2013-2018)
Table Global Blood Plasma Derivatives Consumption Market Share by Type (2013-2018)
Figure Global Blood Plasma Derivatives Consumption Market Share by Type (2013-2018)
Table Global Blood Plasma Derivatives Revenue by Type (2013-2018) ($ million)
Table Global Blood Plasma Derivatives Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Blood Plasma Derivatives Value Market Share by Type (2013-2018)
Table Global Blood Plasma Derivatives Sale Price by Type (2013-2018)
Figure Blood Plasma Derivatives Consumed in Hospitals
Figure Global Blood Plasma Derivatives Market: Hospitals (2013-2018) (K Units)
Figure Global Blood Plasma Derivatives Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Blood Plasma Derivatives Consumed in Clinics
Figure Global Blood Plasma Derivatives Market: Clinics (2013-2018) (K Units)
Figure Global Blood Plasma Derivatives Market: Clinics (2013-2018) ($ Millions)
Figure Global Clinics YoY Growth ($ Millions)
Figure Blood Plasma Derivatives Consumed in Other End Users
Figure Global Blood Plasma Derivatives Market: Other End Users (2013-2018) (K Units)
Figure Global Blood Plasma Derivatives Market: Other End Users (2013-2018) ($ Millions)
Figure Global Other End Users YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Blood Plasma Derivatives Consumption Market Share by Application (2013-2018)
Figure Global Blood Plasma Derivatives Consumption Market Share by Application (2013-2018)
Table Global Blood Plasma Derivatives Value by Application (2013-2018)
Table Global Blood Plasma Derivatives Value Market Share by Application (2013-2018)
Figure Global Blood Plasma Derivatives Value Market Share by Application (2013-2018)
Table Global Blood Plasma Derivatives Sale Price by Application (2013-2018)
Table Global Blood Plasma Derivatives Sales by Players (2016-2018) (K Units)
Table Global Blood Plasma Derivatives Sales Market Share by Players (2016-2018)
Figure Global Blood Plasma Derivatives Sales Market Share by Players in 2016
Figure Global Blood Plasma Derivatives Sales Market Share by Players in 2017
Table Global Blood Plasma Derivatives Revenue by Players (2016-2018) ($ Millions)
Table Global Blood Plasma Derivatives Revenue Market Share by Players (2016-2018)
Figure Global Blood Plasma Derivatives Revenue Market Share by Players in 2016
Figure Global Blood Plasma Derivatives Revenue Market Share by Players in 2017
Table Global Blood Plasma Derivatives Sale Price by Players (2016-2018)
Figure Global Blood Plasma Derivatives Sale Price by Players in 2017
Table Global Blood Plasma Derivatives Manufacturing Base Distribution and Sales Area by Players
Table Players Blood Plasma Derivatives Products Offered
Table Blood Plasma Derivatives Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Blood Plasma Derivatives Consumption by Regions 2013-2018 (K Units)
Table Global Blood Plasma Derivatives Consumption Market Share by Regions 2013-2018
Figure Global Blood Plasma Derivatives Consumption Market Share by Regions 2013-2018
Table Global Blood Plasma Derivatives Value by Regions 2013-2018 ($ Millions)
Table Global Blood Plasma Derivatives Value Market Share by Regions 2013-2018
Figure Global Blood Plasma Derivatives Value Market Share by Regions 2013-2018
Figure Americas Blood Plasma Derivatives Consumption 2013-2018 (K Units)
Figure Americas Blood Plasma Derivatives Value 2013-2018 ($ Millions)
Figure APAC Blood Plasma Derivatives Consumption 2013-2018 (K Units)
Figure APAC Blood Plasma Derivatives Value 2013-2018 ($ Millions)
Figure Europe Blood Plasma Derivatives Consumption 2013-2018 (K Units)
Figure Europe Blood Plasma Derivatives Value 2013-2018 ($ Millions)
Figure Middle East & Africa Blood Plasma Derivatives Consumption 2013-2018 (K Units)
Figure Middle East & Africa Blood Plasma Derivatives Value 2013-2018 ($ Millions)
Table Americas Blood Plasma Derivatives Consumption by Countries (2013-2018) (K Units)
Table Americas Blood Plasma Derivatives Consumption Market Share by Countries (2013-2018)
Figure Americas Blood Plasma Derivatives Consumption Market Share by Countries in 2017
Table Americas Blood Plasma Derivatives Value by Countries (2013-2018) ($ Millions)
Table Americas Blood Plasma Derivatives Value Market Share by Countries (2013-2018)
Figure Americas Blood Plasma Derivatives Value Market Share by Countries in 2017
Table Americas Blood Plasma Derivatives Consumption by Type (2013-2018) (K Units)
Table Americas Blood Plasma Derivatives Consumption Market Share by Type (2013-2018)
Figure Americas Blood Plasma Derivatives Consumption Market Share by Type in 2017
Table Americas Blood Plasma Derivatives Consumption by Application (2013-2018) (K Units)
Table Americas Blood Plasma Derivatives Consumption Market Share by Application (2013-2018)
Figure Americas Blood Plasma Derivatives Consumption Market Share by Application in 2017
Figure United States Blood Plasma Derivatives Consumption Growth 2013-2018 (K Units)
Figure United States Blood Plasma Derivatives Value Growth 2013-2018 ($ Millions)
Figure Canada Blood Plasma Derivatives Consumption Growth 2013-2018 (K Units)
Figure Canada Blood Plasma Derivatives Value Growth 2013-2018 ($ Millions)
Figure Mexico Blood Plasma Derivatives Consumption Growth 2013-2018 (K Units)
Figure Mexico Blood Plasma Derivatives Value Growth 2013-2018 ($ Millions)
Table APAC Blood Plasma Derivatives Consumption by Countries (2013-2018) (K Units)
Table APAC Blood Plasma Derivatives Consumption Market Share by Countries (2013-2018)
Figure APAC Blood Plasma Derivatives Consumption Market Share by Countries in 2017
Table APAC Blood Plasma Derivatives Value by Countries (2013-2018) ($ Millions)
Table APAC Blood Plasma Derivatives Value Market Share by Countries (2013-2018)
Figure APAC Blood Plasma Derivatives Value Market Share by Countries in 2017
Table APAC Blood Plasma Derivatives Consumption by Type (2013-2018) (K Units)
Table APAC Blood Plasma Derivatives Consumption Market Share by Type (2013-2018)
Figure APAC Blood Plasma Derivatives Consumption Market Share by Type in 2017
Table APAC Blood Plasma Derivatives Consumption by Application (2013-2018) (K Units)
Table APAC Blood Plasma Derivatives Consumption Market Share by Application (2013-2018)
Figure APAC Blood Plasma Derivatives Consumption Market Share by Application in 2017
Figure China Blood Plasma Derivatives Consumption Growth 2013-2018 (K Units)
Figure China Blood Plasma Derivatives Value Growth 2013-2018 ($ Millions)
Figure Japan Blood Plasma Derivatives Consumption Growth 2013-2018 (K Units)
Figure Japan Blood Plasma Derivatives Value Growth 2013-2018 ($ Millions)
Figure Korea Blood Plasma Derivatives Consumption Growth 2013-2018 (K Units)
Figure Korea Blood Plasma Derivatives Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Blood Plasma Derivatives Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Blood Plasma Derivatives Value Growth 2013-2018 ($ Millions)
Figure India Blood Plasma Derivatives Consumption Growth 2013-2018 (K Units)
Figure India Blood Plasma Derivatives Value Growth 2013-2018 ($ Millions)
Figure Australia Blood Plasma Derivatives Consumption Growth 2013-2018 (K Units)
Figure Australia Blood Plasma Derivatives Value Growth 2013-2018 ($ Millions)
Table Europe Blood Plasma Derivatives Consumption by Countries (2013-2018) (K Units)
Table Europe Blood Plasma Derivatives Consumption Market Share by Countries (2013-2018)
Figure Europe Blood Plasma Derivatives Consumption Market Share by Countries in 2017
Table Europe Blood Plasma Derivatives Value by Countries (2013-2018) ($ Millions)
Table Europe Blood Plasma Derivatives Value Market Share by Countries (2013-2018)
Figure Europe Blood Plasma Derivatives Value Market Share by Countries in 2017
Table Europe Blood Plasma Derivatives Consumption by Type (2013-2018) (K Units)
Table Europe Blood Plasma Derivatives Consumption Market Share by Type (2013-2018)
Figure Europe Blood Plasma Derivatives Consumption Market Share by Type in 2017
Table Europe Blood Plasma Derivatives Consumption by Application (2013-2018) (K Units)
Table Europe Blood Plasma Derivatives Consumption Market Share by Application (2013-2018)
Figure Europe Blood Plasma Derivatives Consumption Market Share by Application in 2017
Figure Germany Blood Plasma Derivatives Consumption Growth 2013-2018 (K Units)
Figure Germany Blood Plasma Derivatives Value Growth 2013-2018 ($ Millions)
Figure France Blood Plasma Derivatives Consumption Growth 2013-2018 (K Units)
Figure France Blood Plasma Derivatives Value Growth 2013-2018 ($ Millions)
Figure UK Blood Plasma Derivatives Consumption Growth 2013-2018 (K Units)
Figure UK Blood Plasma Derivatives Value Growth 2013-2018 ($ Millions)
Figure Italy Blood Plasma Derivatives Consumption Growth 2013-2018 (K Units)
Figure Italy Blood Plasma Derivatives Value Growth 2013-2018 ($ Millions)
Figure Russia Blood Plasma Derivatives Consumption Growth 2013-2018 (K Units)
Figure Russia Blood Plasma Derivatives Value Growth 2013-2018 ($ Millions)
Figure Spain Blood Plasma Derivatives Consumption Growth 2013-2018 (K Units)
Figure Spain Blood Plasma Derivatives Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Blood Plasma Derivatives Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Blood Plasma Derivatives Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Blood Plasma Derivatives Consumption Market Share by Countries in 2017
Table Middle East & Africa Blood Plasma Derivatives Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Blood Plasma Derivatives Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Blood Plasma Derivatives Value Market Share by Countries in 2017
Table Middle East & Africa Blood Plasma Derivatives Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Blood Plasma Derivatives Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Blood Plasma Derivatives Consumption Market Share by Type in 2017
Table Middle East & Africa Blood Plasma Derivatives Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Blood Plasma Derivatives Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Blood Plasma Derivatives Consumption Market Share by Application in 2017
Figure Egypt Blood Plasma Derivatives Consumption Growth 2013-2018 (K Units)
Figure Egypt Blood Plasma Derivatives Value Growth 2013-2018 ($ Millions)
Figure South Africa Blood Plasma Derivatives Consumption Growth 2013-2018 (K Units)
Figure South Africa Blood Plasma Derivatives Value Growth 2013-2018 ($ Millions)
Figure Israel Blood Plasma Derivatives Consumption Growth 2013-2018 (K Units)
Figure Israel Blood Plasma Derivatives Value Growth 2013-2018 ($ Millions)
Figure Turkey Blood Plasma Derivatives Consumption Growth 2013-2018 (K Units)
Figure Turkey Blood Plasma Derivatives Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Blood Plasma Derivatives Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Blood Plasma Derivatives Value Growth 2013-2018 ($ Millions)
Table Blood Plasma Derivatives Distributors List
Table Blood Plasma Derivatives Customer List
Figure Global Blood Plasma Derivatives Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Blood Plasma Derivatives Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Blood Plasma Derivatives Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Blood Plasma Derivatives Consumption Market Forecast by Regions
Table Global Blood Plasma Derivatives Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Blood Plasma Derivatives Value Market Share Forecast by Regions
Figure Americas Blood Plasma Derivatives Consumption 2018-2023 (K Units)
Figure Americas Blood Plasma Derivatives Value 2018-2023 ($ Millions)
Figure APAC Blood Plasma Derivatives Consumption 2018-2023 (K Units)
Figure APAC Blood Plasma Derivatives Value 2018-2023 ($ Millions)
Figure Europe Blood Plasma Derivatives Consumption 2018-2023 (K Units)
Figure Europe Blood Plasma Derivatives Value 2018-2023 ($ Millions)
Figure Middle East & Africa Blood Plasma Derivatives Consumption 2018-2023 (K Units)
Figure Middle East & Africa Blood Plasma Derivatives Value 2018-2023 ($ Millions)
Figure United States Blood Plasma Derivatives Consumption 2018-2023 (K Units)
Figure United States Blood Plasma Derivatives Value 2018-2023 ($ Millions)
Figure Canada Blood Plasma Derivatives Consumption 2018-2023 (K Units)
Figure Canada Blood Plasma Derivatives Value 2018-2023 ($ Millions)
Figure Mexico Blood Plasma Derivatives Consumption 2018-2023 (K Units)
Figure Mexico Blood Plasma Derivatives Value 2018-2023 ($ Millions)
Figure Brazil Blood Plasma Derivatives Consumption 2018-2023 (K Units)
Figure Brazil Blood Plasma Derivatives Value 2018-2023 ($ Millions)
Figure China Blood Plasma Derivatives Consumption 2018-2023 (K Units)
Figure China Blood Plasma Derivatives Value 2018-2023 ($ Millions)
Figure Japan Blood Plasma Derivatives Consumption 2018-2023 (K Units)
Figure Japan Blood Plasma Derivatives Value 2018-2023 ($ Millions)
Figure Korea Blood Plasma Derivatives Consumption 2018-2023 (K Units)
Figure Korea Blood Plasma Derivatives Value 2018-2023 ($ Millions)
Figure Southeast Asia Blood Plasma Derivatives Consumption 2018-2023 (K Units)
Figure Southeast Asia Blood Plasma Derivatives Value 2018-2023 ($ Millions)
Figure India Blood Plasma Derivatives Consumption 2018-2023 (K Units)
Figure India Blood Plasma Derivatives Value 2018-2023 ($ Millions)
Figure Australia Blood Plasma Derivatives Consumption 2018-2023 (K Units)
Figure Australia Blood Plasma Derivatives Value 2018-2023 ($ Millions)
Figure Germany Blood Plasma Derivatives Consumption 2018-2023 (K Units)
Figure Germany Blood Plasma Derivatives Value 2018-2023 ($ Millions)
Figure France Blood Plasma Derivatives Consumption 2018-2023 (K Units)
Figure France Blood Plasma Derivatives Value 2018-2023 ($ Millions)
Figure UK Blood Plasma Derivatives Consumption 2018-2023 (K Units)
Figure UK Blood Plasma Derivatives Value 2018-2023 ($ Millions)
Figure Italy Blood Plasma Derivatives Consumption 2018-2023 (K Units)
Figure Italy Blood Plasma Derivatives Value 2018-2023 ($ Millions)
Figure Russia Blood Plasma Derivatives Consumption 2018-2023 (K Units)
Figure Russia Blood Plasma Derivatives Value 2018-2023 ($ Millions)
Figure Spain Blood Plasma Derivatives Consumption 2018-2023 (K Units)
Figure Spain Blood Plasma Derivatives Value 2018-2023 ($ Millions)
Figure Egypt Blood Plasma Derivatives Consumption 2018-2023 (K Units)
Figure Egypt Blood Plasma Derivatives Value 2018-2023 ($ Millions)
Figure South Africa Blood Plasma Derivatives Consumption 2018-2023 (K Units)
Figure South Africa Blood Plasma Derivatives Value 2018-2023 ($ Millions)
Figure Israel Blood Plasma Derivatives Consumption 2018-2023 (K Units)
Figure Israel Blood Plasma Derivatives Value 2018-2023 ($ Millions)
Figure Turkey Blood Plasma Derivatives Consumption 2018-2023 (K Units)
Figure Turkey Blood Plasma Derivatives Value 2018-2023 ($ Millions)
Figure GCC Countries Blood Plasma Derivatives Consumption 2018-2023 (K Units)
Figure GCC Countries Blood Plasma Derivatives Value 2018-2023 ($ Millions)
Table Global Blood Plasma Derivatives Consumption Forecast by Type (2018-2023) (K Units)
Table Global Blood Plasma Derivatives Consumption Market Share Forecast by Type (2018-2023)
Table Global Blood Plasma Derivatives Value Forecast by Type (2018-2023) ($ Millions)
Table Global Blood Plasma Derivatives Value Market Share Forecast by Type (2018-2023)
Table Global Blood Plasma Derivatives Consumption Forecast by Application (2018-2023) (K Units)
Table Global Blood Plasma Derivatives Consumption Market Share Forecast by Application (2018-2023)
Table Global Blood Plasma Derivatives Value Forecast by Application (2018-2023) ($ Millions)
Table Global Blood Plasma Derivatives Value Market Share Forecast by Application (2018-2023)
Table Grifols, S.A. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Grifols, S.A. Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Grifols, S.A. Blood Plasma Derivatives Market Share (2016-2018)
Table SK Plasma Co., Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table SK Plasma Co., Ltd. Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2016-2018)
Figure SK Plasma Co., Ltd. Blood Plasma Derivatives Market Share (2016-2018)
Table Fusion Health Care Pvt. Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Fusion Health Care Pvt. Ltd. Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Fusion Health Care Pvt. Ltd. Blood Plasma Derivatives Market Share (2016-2018)
Table Biotest AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biotest AG Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Biotest AG Blood Plasma Derivatives Market Share (2016-2018)
Table Green Cross Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Green Cross Corporation Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Green Cross Corporation Blood Plasma Derivatives Market Share (2016-2018)
Table Baxter International Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Baxter International Inc. Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Baxter International Inc. Blood Plasma Derivatives Market Share (2016-2018)
Table LFB S.A. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table LFB S.A. Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2016-2018)
Figure LFB S.A. Blood Plasma Derivatives Market Share (2016-2018)
Table Octapharma AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Octapharma AG Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Octapharma AG Blood Plasma Derivatives Market Share (2016-2018)
Table CSL Limited Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Limited Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2016-2018)
Figure CSL Limited Blood Plasma Derivatives Market Share (2016-2018)
Table Shire Plc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shire Plc. Blood Plasma Derivatives Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Shire Plc. Blood Plasma Derivatives Market Share (2016-2018)
Table China Biologic Products, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kedrion Biopharma, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BDI Pharma, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hualan Biological Engineering, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors